Schiller May Be Forced to Pay Back Valeant Up to $26.1 Million

  • Clawback policy allows company to recoup pay after restatement
  • Penalty applies even if executive no longer works for company

Valeant Management Shakeup: What Comes Next?

Howard Schiller, the embattled Valeant Pharmaceuticals International Inc. director, may be forced to pay back some of the $26.1 million in incentive compensation he received as chief financial officer in 2014.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.